Stay updated on ADVANCE Study: DTG Triple vs EFV Triple Clinical Trial
Sign up to get notified when there's something new on the ADVANCE Study: DTG Triple vs EFV Triple Clinical Trial page.

Latest updates to the ADVANCE Study: DTG Triple vs EFV Triple Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe ADVANCE HIV treatment study record is displayed, including its design, eligibility criteria, interventions, outcome measures, publications, and data-sharing plan, where a 403 error had appeared before.SummaryDifference57%

- Check16 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA sitewide NIH notice announces updates and FAQs about the agency’s transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check30 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check57 days agoChange DetectedA 403 Forbidden error page is now displayed for the study record, and core documents/sections such as the Informed Consent Form, Study Protocol, and IPD sharing information appear to be removed, limiting access to essential study information.SummaryDifference20%

Stay in the know with updates to ADVANCE Study: DTG Triple vs EFV Triple Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVANCE Study: DTG Triple vs EFV Triple Clinical Trial page.